Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
8
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
8
×
clinical trials
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
fda
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
alnylam pharmaceuticals
biotech
cancer
hereditary transthyretin amyloidosis
inotersen
new york
onpattro
patisiran
pfizer
What
drug
8
×
medicine
8
×
fda
approved
cancer
new
alnylam
disease
oks
post
rnai
specifically
aces
afternoon
alnylam’s
alzheimer's
announced
approves
bad
big
brain
brexanolone
case
cells
ceo
cholesterol
data
deeper
depression
devastating
disorder
dna
doses
eisai
ema
employ
europe
failed
fast
fatty
Language
unset
Current search:
medicine
×
drug
×
" new york top stories "
×
" boston top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug